dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Terviseamet
Väljaminev dokumentAvalik

Kiri

Terviseamet · 17. detsember 2024
Viit
11.2-1/24/12872-1
Registreeritud
17. detsember 2024
Dokumendi liik
Väljaminev dokument
Funktsioon
11.2 SULETUD 2025 Turustamise eelne järelevalve (pre-marketing surveillance)
Sari
11.2-1 Meditsiiniseadmete kliiniliste uuringute ja toimivusuuringute dokumendid (taotlused, load, muud teavitused ja kirjavahetus)
Toimik
11.2-1/2024
Vastutaja
Merili Saar-Abroi (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond)

Failid

  • 📎Notification of Organizational Transfer of the Estonian Medical Devices Department.msg74 KB
  • 📎Notification of Organizational Transfer of the Estonian Medical Devices Department.msg74 KB
  • 📎Notification of Organizational Transfer of the Estonian Medical Devices Department.msg89 KB
  • 📎Notification of Organizational Transfer of the Estonian Medical Devices Department.msg70 KB
  • 📎Notification of Organizational Transfer of the Estonian Medical Devices Department.msg78 KB
  • 📎Notification of Organizational Transfer of the Estonian Medical Devices Department.msg81 KB

Sisu (failidest)

Saatja: Meditsiiniseadmed (Medical Devices) </O=SOTSIAALMINISTEERIUM/OU=FIRST ADMINISTRATIVE GROUP/CN=RECIPIENTS/CN=MSOC5ACD8534204CFDEC17D568B7204AE5C891A7D> Saaja: Birgit Teppo - Optimapharm Teema: Notification of Organizational Transfer of the Estonian Medical Devices Department Dear Sponsor, We wish to formally inform you that, effective January 1, 2025, the Estonian Medical Devices Department will transition from the Health Board to the State Agency of Medicines. This reorganization will transfer all employees, resources, and operations previously under the Health Board to the State Agency of Medicines in their entirety. Please note that this transition will not impose any additional obligations on study sponsors. Moreover, it will have no impact on your ongoing clinical studies. Your initial application, dossier, and all related documentation and data will be automatically transferred to the State Agency of Medicines. Starting from January 1, 2025, please direct all correspondence to the following email address: [email protected]. Additionally, all public information regarding the conduct of clinical studies for medical devices and in vitro diagnostic medical devices will be available on our website at ravimiamet.ee. We remain committed to supporting your studies and ensuring a smooth transition during this organizational change. Should you have any questions or require further clarification, please do not hesitate to contact us. All the best, Merili Saar-Abroi peaspetsialist meditsiiniseadmete osakond +372 554 3041 [email protected]<mailto:[email protected]> | [email protected]<mailto:[email protected]> [cid:[email protected]] Terviseamet +372 794 3500 [email protected]<mailto:[email protected]> www.terviseamet.ee<http://www.terviseamet.ee/> Paldiski mnt 81, 10614 Tallinn Käesolev kiri on konfidentsiaalne ning mõeldud kasutamiseks kirja päises nimetatud isikule/asutusele. Käesoleva kirja mistahes viisil kasutamine või kopeerimine isiku poolt, kes ei ole märgitud selle adressaadiks, on keelatud. Kui te olete saanud käesoleva kirja ekslikult, palume sellest koheselt teavitada kirja saatjat ning kustutada saadud kiri koos kõikide lisadega. Saatja: Meditsiiniseadmed (Medical Devices) </O=SOTSIAALMINISTEERIUM/OU=FIRST ADMINISTRATIVE GROUP/CN=RECIPIENTS/CN=MSOC5ACD8534204CFDEC17D568B7204AE5C891A7D> Saaja: Emilija Mitreska, [email protected], Farinha, Ana, Katarzyna Stankiewicz, Andreea-Elena Stefan Teema: Notification of Organizational Transfer of the Estonian Medical Devices Department Dear Sponsor, We wish to formally inform you that, effective January 1, 2025, the Estonian Medical Devices Department will transition from the Health Board to the State Agency of Medicines. This reorganization will transfer all employees, resources, and operations previously under the Health Board to the State Agency of Medicines in their entirety. Please note that this transition will not impose any additional obligations on study sponsors. Moreover, it will have no impact on your ongoing clinical studies. Your initial application, dossier, and all related documentation and data will be automatically transferred to the State Agency of Medicines. Starting from January 1, 2025, please direct all correspondence to the following email address: [email protected]. Additionally, all public information regarding the conduct of clinical studies for medical devices and in vitro diagnostic medical devices will be available on our website at ravimiamet.ee. We remain committed to supporting your studies and ensuring a smooth transition during this organizational change. Should you have any questions or require further clarification, please do not hesitate to contact us. All the best, Merili Saar-Abroi peaspetsialist meditsiiniseadmete osakond +372 554 3041 [email protected]<mailto:[email protected]> | [email protected]<mailto:[email protected]> [cid:[email protected]] Terviseamet +372 794 3500 [email protected]<mailto:[email protected]> www.terviseamet.ee<http://www.terviseamet.ee/> Paldiski mnt 81, 10614 Tallinn Käesolev kiri on konfidentsiaalne ning mõeldud kasutamiseks kirja päises nimetatud isikule/asutusele. Käesoleva kirja mistahes viisil kasutamine või kopeerimine isiku poolt, kes ei ole märgitud selle adressaadiks, on keelatud. Kui te olete saanud käesoleva kirja ekslikult, palume sellest koheselt teavitada kirja saatjat ning kustutada saadud kiri koos kõikide lisadega. Saatja: Meditsiiniseadmed (Medical Devices) </O=SOTSIAALMINISTEERIUM/OU=FIRST ADMINISTRATIVE GROUP/CN=RECIPIENTS/CN=MSOC5ACD8534204CFDEC17D568B7204AE5C891A7D> Saaja: Amaya, Laura, Guntaka, Rajesh, Ceulemans, Carolien, Murphy, Kendra, Velimirović, Isidora, Fitzgerald, Oriana [email protected] Teema: Notification of Organizational Transfer of the Estonian Medical Devices Department Dear Sponsor, We wish to formally inform you that, effective January 1st, 2025, the Estonian Medical Devices Department will transition from the Health Board to the State Agency of Medicines. This reorganization will transfer all employees, resources, and operations previously under the Health Board to the State Agency of Medicines in their entirety. Please note that this transition will not impose any additional obligations on study sponsors. Moreover, it will have no impact on your ongoing clinical studies. Your initial application, dossier, and all related documentation and data will be automatically transferred to the State Agency of Medicines. Starting from January 1st, 2025, please direct all correspondence to the following email address: [email protected]. Additionally, all public information regarding the conduct of clinical studies for medical devices and in vitro diagnostic medical devices will be available on our website at ravimiamet.ee. We remain committed to supporting your studies and ensuring a smooth transition during this organizational change. Should you have any questions or require further clarification, please do not hesitate to contact us. All the best, Merili Saar-Abroi Chief Specialist Department of Medical Devices Phone +372 554 3041 [email protected]<mailto:[email protected]> | [email protected]<mailto:[email protected]> [cid:[email protected]] Terviseamet | Health Board +372 794 3500 [email protected]<mailto:[email protected]> www.terviseamet.ee<http://www.terviseamet.ee/> Paldiski mnt 81, 10614 Tallinn This e-mail is confidential and meant for use by the person named in the letterhead. Any use in any way or copying of it by a person not marked as the addressee thereof is prohibited. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments. Saatja: Meditsiiniseadmed (Medical Devices) </O=SOTSIAALMINISTEERIUM/OU=FIRST ADMINISTRATIVE GROUP/CN=RECIPIENTS/CN=MSOC5ACD8534204CFDEC17D568B7204AE5C891A7D> Saaja: CompetentAuthoritySubmissions, Mhairi Coyle - Contractor Teema: Notification of Organizational Transfer of the Estonian Medical Devices Department Dear Sponsor, We wish to formally inform you that, effective January 1st, 2025, the Estonian Medical Devices Department will transition from the Health Board to the State Agency of Medicines. This reorganization will transfer all employees, resources, and operations previously under the Health Board to the State Agency of Medicines in their entirety. Please note that this transition will not impose any additional obligations on study sponsors. Moreover, it will have no impact on your ongoing clinical studies. Your initial application, dossier, and all related documentation and data will be automatically transferred to the State Agency of Medicines. Starting from January 1st, 2025, please direct all correspondence to the following email address: [email protected]. Additionally, all public information regarding the conduct of clinical studies for medical devices and in vitro diagnostic medical devices will be available on our website at ravimiamet.ee. We remain committed to supporting your studies and ensuring a smooth transition during this organizational change. Should you have any questions or require further clarification, please do not hesitate to contact us. All the best, Merili Saar-Abroi Chief Specialist Department of Medical Devices Phone +372 554 3041 [email protected]<mailto:[email protected]> | [email protected]<mailto:[email protected]> [cid:[email protected]] Terviseamet | Health Board +372 794 3500 [email protected]<mailto:[email protected]> www.terviseamet.ee<http://www.terviseamet.ee/> Paldiski mnt 81, 10614 Tallinn This e-mail is confidential and meant for use by the person named in the letterhead. Any use in any way or copying of it by a person not marked as the addressee thereof is prohibited. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments. Saatja: Meditsiiniseadmed (Medical Devices) </O=SOTSIAALMINISTEERIUM/OU=FIRST ADMINISTRATIVE GROUP/CN=RECIPIENTS/CN=MSOC5ACD8534204CFDEC17D568B7204AE5C891A7D> Saaja: [email protected] Teema: Notification of Organizational Transfer of the Estonian Medical Devices Department Dear Sponsor, We wish to formally inform you that, effective January 1, 2025, the Estonian Medical Devices Department will transition from the Health Board to the State Agency of Medicines. This reorganization will transfer all employees, resources, and operations previously under the Health Board to the State Agency of Medicines in their entirety. Please note that this transition will not impose any additional obligations on study sponsors. Moreover, it will have no impact on your ongoing clinical studies. Your initial application, dossier, and all related documentation and data will be automatically transferred to the State Agency of Medicines. Starting from January 1, 2025, please direct all correspondence to the following email address: [email protected]. Additionally, all public information regarding the conduct of clinical studies for medical devices and in vitro diagnostic medical devices will be available on our website at ravimiamet.ee. We remain committed to supporting your studies and ensuring a smooth transition during this organizational change. Should you have any questions or require further clarification, please do not hesitate to contact us. All the best, Merili Saar-Abroi peaspetsialist meditsiiniseadmete osakond +372 554 3041 [email protected]<mailto:[email protected]> | [email protected]<mailto:[email protected]> [cid:[email protected]] Terviseamet +372 794 3500 [email protected]<mailto:[email protected]> www.terviseamet.ee<http://www.terviseamet.ee/> Paldiski mnt 81, 10614 Tallinn Käesolev kiri on konfidentsiaalne ning mõeldud kasutamiseks kirja päises nimetatud isikule/asutusele. Käesoleva kirja mistahes viisil kasutamine või kopeerimine isiku poolt, kes ei ole märgitud selle adressaadiks, on keelatud. Kui te olete saanud käesoleva kirja ekslikult, palume sellest koheselt teavitada kirja saatjat ning kustutada saadud kiri koos kõikide lisadega. Saatja: Merili Saar-Abroi </O=SOTSIAALMINISTEERIUM/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=B3DFF8D626E3498AA01430D77D67694E-MER> Saaja: [email protected], [email protected], [email protected] Teema: Notification of Organizational Transfer of the Estonian Medical Devices Department Dear Sponsor, We wish to formally inform you that, effective January 1st, 2025, the Estonian Medical Devices Department will transition from the Health Board to the State Agency of Medicines. This reorganization will transfer all employees, resources, and operations previously under the Health Board to the State Agency of Medicines in their entirety. Please note that this transition will not impose any additional obligations on study sponsors. Moreover, it will have no impact on your ongoing clinical studies. Your initial application, dossier, and all related documentation and data will be automatically transferred to the State Agency of Medicines. Starting from January 1st, 2025, please direct all correspondence to the following email address: [email protected]. Additionally, all public information regarding the conduct of clinical studies for medical devices and in vitro diagnostic medical devices will be available on our website at ravimiamet.ee. We remain committed to supporting your studies and ensuring a smooth transition during this organizational change. Should you have any questions or require further clarification, please do not hesitate to contact us. All the best, Merili Saar-Abroi Chief Specialist Department of Medical Devices Phone +372 554 3041 [email protected]<mailto:[email protected]> | [email protected]<mailto:[email protected]> [cid:[email protected]] Terviseamet | Health Board +372 794 3500 [email protected]<mailto:[email protected]> www.terviseamet.ee<http://www.terviseamet.ee/> Paldiski mnt 81, 10614 Tallinn This e-mail is confidential and meant for use by the person named in the letterhead. Any use in any way or copying of it by a person not marked as the addressee thereof is prohibited. If you have got this e-mail by mistake, please notify of it the sender without delay and delete the received e-mail together with all its attachments.
Allikas: Terviseamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel